We are live on ! Find out more
SCA

Snowden Capital Advisors Portfolio holdings

AUM $3.76B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+23.4%
3 Year Est. Return
+84.18%
5 Year Est. Return
+103.17%
10 Year Est. Return
+383.86%
AUM
$2.21B
AUM Growth
-$17.6M
Cap. Flow
+$114M
Cap. Flow %
5.18%
Top 10 Hldgs %
15.85%
Holding
1,186
New
65
Increased
567
Reduced
412
Closed
77

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 10.27%
3 Financials 8.32%
4 Consumer Discretionary 7.27%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
576
Conagra Brands
CAG
$7.11B
$603K 0.03%
18,498
+1,199
+7% +$41.2K
CATY icon
577
Cathay General Bancorp
CATY
$4.26B
$603K 0.03%
15,688
-100
-0.6% -$4.16K
FCX icon
578
Freeport-McMoran
FCX
$95.5B
$602K 0.03%
22,050
-218,142
-91% -$6.38M
POWI icon
579
Power Integrations
POWI
$3.29B
$599K 0.03%
9,319
+2,459
+36% +$184K
DBC icon
580
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$597K 0.03%
25,003
+702
+3% +$17.8K
KKR icon
581
KKR & Co
KKR
$92.8B
$595K 0.03%
13,844
-4,127
-23% -$209K
RSPH icon
582
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$775M
$595K 0.03%
+23,690
New +$649K
PWR icon
583
Quanta Services
PWR
$100B
$594K 0.03%
4,669
-1,382
-23% -$189K
OKE icon
584
Oneok
OKE
$55.4B
$592K 0.03%
11,560
+1,376
+14% +$81.8K
DBEF icon
585
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.33B
$591K 0.03%
17,654
GSK icon
586
GSK
GSK
$104B
$590K 0.03%
20,067
-7,693
-28% -$292K
LMAT icon
587
LeMaitre Vascular
LMAT
$1.85B
$581K 0.03%
11,469
+2,634
+30% +$132K
CHRD icon
588
Chord Energy
CHRD
$7.46B
$579K 0.03%
4,237
+674
+19% +$86.4K
TTEK icon
589
Tetra Tech
TTEK
$8.89B
$579K 0.03%
22,540
+3,790
+20% +$106K
VRSK icon
590
Verisk Analytics
VRSK
$24.7B
$579K 0.03%
3,399
-1,263
-27% -$236K
LSTR icon
591
Landstar System
LSTR
$6.01B
$578K 0.03%
4,005
+445
+13% +$66.3K
NBIX icon
592
Neurocrine Biosciences
NBIX
$16.2B
$578K 0.03%
5,450
+1,291
+31% +$131K
WELL icon
593
Welltower
WELL
$170B
$577K 0.03%
8,971
+793
+10% +$62K
ROK icon
594
Rockwell Automation
ROK
$49.2B
$573K 0.03%
2,665
-806
-23% -$188K
VMBS icon
595
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$572K 0.03%
12,699
+279
+2% +$13.3K
EME icon
596
Emcor
EME
$35.7B
$571K 0.03%
4,945
+1,012
+26% +$116K
FPX icon
597
First Trust US Equity Opportunities ETF
FPX
$1.49B
$569K 0.03%
7,025
+256
+4% +$22.5K
MTUM icon
598
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
$566K 0.03%
4,322
-433
-9% -$60.7K
ALSN icon
599
Allison Transmission
ALSN
$9.64B
$565K 0.03%
16,741
+2,930
+21% +$110K
BUFD icon
600
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.98B
$565K 0.03%
29,575
-4,000
-12% -$79.4K

Similar funds

Snowden Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Snowden Capital Advisors held 1,186 positions worth $2.21B, down 0.79% from $2.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Snowden Capital Advisors deployed $114M of net new capital in Q3 2022, opening 65 new positions and adding to 567 existing holdings. Its largest new stake was Jabil: 51,936 shares worth $3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard ESG US Stock ETF, an estimated $8.45M trimmed.

  • Snowden Capital Advisors's largest Q3 2022 buy was Jabil: 51,936 shares worth $3M.
  • Snowden Capital Advisors added most to Schwab US Dividend Equity ETF in Q3 2022, an estimated $14.7M increase.
  • Snowden Capital Advisors's biggest Q3 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $8.45M.
  • Snowden Capital Advisors fully exited Nutrien in Q3 2022, selling an estimated $8.79M.
  • Snowden Capital Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q3 2022.
  • Snowden Capital Advisors opened 65 new positions and closed 77 in Q3 2022.
  • Snowden Capital Advisors's portfolio value fell 0.79% quarter-over-quarter to $2.21B.

Based on Snowden Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.